Retinal antioxidant defense systems

The retinal antioxidant defense system is a multi-layered network of enzymatic and non-enzymatic components that maintain redox homeostasis in the highly metabolic environment of the retina. Primary enzymatic defenses include superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), which neutralize reactive oxygen species (ROS) generated by mitochondrial respiration and light exposure. Non-enzymatic antioxidants such as glutathione, vitamins C and E, and macular pigments like lutein and zeaxanthin provide additional scavenging capacity. The system is largely regulated by the transcription factor Nrf2, which upregulates the expression of antioxidant genes in response to oxidative stress. Chronic oxidative stress and the subsequent failure of these defense systems are implicated in the pathogenesis of age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma. Therapeutic interventions aim to bolster this system through direct antioxidant supplementation (e.g., AREDS2 formula) or by activating endogenous pathways like Nrf2 to prevent retinal cell death and preserve vision.

Other names

Ocular antioxidant defense systemRetinal antioxidant networkRetinal redox homeostasis systemEndogenous retinal antioxidant system

The mechanism of action involves the direct scavenging of reactive oxygen species (ROS), the activation of the Nrf2-Keap1 signaling pathway to upregulate endogenous antioxidant enzymes, and the provision of essential cofactors like zinc for enzyme activity. These actions collectively reduce lipid peroxidation, DNA damage, and protein oxidation, thereby preventing apoptosis in retinal pigment epithelium (RPE) and photoreceptor cells.